


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:48:06Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405474" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405474</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ncomms</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-id journal-id-type="pmc-domain-id">2873</journal-id><journal-id journal-id-type="pmc-domain">ncomms</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405474</article-id><article-id pub-id-type="pmcid-ver">PMC12405474.1</article-id><article-id pub-id-type="pmcaid">12405474</article-id><article-id pub-id-type="pmcaiid">12405474</article-id><article-id pub-id-type="pmid">40897707</article-id><article-id pub-id-type="doi">10.1038/s41467-025-63348-8</article-id><article-id pub-id-type="publisher-id">63348</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Defective neutrophil-derived exosomes facilitate macrophage activation through miR-122-5p in Beh&#231;et&#8217;s disease</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Yu</surname><given-names initials="X">Xin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="M">Menghao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Kang</surname><given-names initials="N">Na</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Li</surname><given-names initials="C">Chaoran</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zhimian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ao</surname><given-names initials="Y">Yiyuan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="L">Lu</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="X">Xiao&#8217;ou</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Y">Yeling</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="L">Lidan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="L">Li</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shen</surname><given-names initials="M">Min</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2150-7540</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="J">Jinjing</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="Y">Yan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="F">Fengchun</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0641-2837</contrib-id><name name-style="western"><surname>Chen</surname><given-names initials="H">Hua</given-names></name><address><email>chenhua@pumch.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3165-8185</contrib-id><name name-style="western"><surname>Zheng</surname><given-names initials="W">Wenjie</given-names></name><address><email>zhengwj@pumch.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/027s68j25</institution-id><institution-id institution-id-type="GRID">grid.424020.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 1054</institution-id><institution>Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases, </institution><institution>Ministry of Science &amp; Technology, </institution></institution-wrap>Beijing, China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03cve4549</institution-id><institution-id institution-id-type="GRID">grid.12527.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 0662 3178</institution-id><institution>Tsinghua-Peking Center for Life Sciences, </institution><institution>Tsinghua University, </institution></institution-wrap>Beijing, China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040rwep31</institution-id><institution-id institution-id-type="GRID">grid.452694.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0644 5625</institution-id><institution>Department of Rheumatology, </institution><institution>Peking University Shougang Hospital, </institution></institution-wrap>Beijing, China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02drdmm93</institution-id><institution-id institution-id-type="GRID">grid.506261.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0706 7839</institution-id><institution>School of Nursing, </institution><institution>Chinese Academy of Medical Sciences &amp; Peking Union Medical College, </institution></institution-wrap>Beijing, China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><issue-id pub-id-type="pmc-issue-id">478256</issue-id><elocation-id>8186</elocation-id><history><date date-type="received"><day>5</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>18</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="41467_2025_Article_63348.pdf"/><abstract id="Abs1"><p id="Par1">Beh&#231;et&#8217;s disease (BD) is a life-threatening systemic vasculitis characterized by polymorphonuclear neutrophils (PMN) and macrophage activation. However, the interaction of PMN and macrophages remains elusive. To elucidate the potential dysregulation of BD PMN exosomes on macrophage activation, PMN exosomes from both BD patients and healthy controls are isolated, quantified and incubated with macrophages. We find that BD PMN exosomes are decreased and negatively correlated with C-reactive protein (CRP). PMN exosomes can suppress IL-6, TNF, CD80 and CD86 expressions on macrophages, which are attenuated in BD PMN exosomes. In addition, by miRNA sequencing of PMN exosomes, RNA sequencing of miRNA-transfected macrophages, and dual luciferase reporter assay validation of the miRNA target, we find that miR-122-5p is decreased in BD PMN exosomes, targeting IRF5, suppressing TLR4 signaling and IFN-&#946; autocrine, eventually downregulating macrophage activation. Our study illustrates that BD PMN exosomes are decreased in both quantity and miR-122-5p, which impairs the potential immunoregulatory effects&#160;on macrophages through degrading IRF5 and suppressing IFN-&#946; autocrine, shedding light on the interaction mechanism between PMN and macrophages.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">Beh&#231;et&#8217;s disease (BD) is characterized by polymorphonuclear neutrophils (PMN) and macrophage activation, but their interaction remains elusive. The authors here find PMN exosomes from BD patients are attenuated in suppressing proinflammatory macrophages when cocultured in vitro with the mechanism of decreased miR-122-5p/IRF5/TLR4 signaling and IFN-&#946; autocrine pathway.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Vasculitis syndromes</kwd><kwd>Inflammatory diseases</kwd><kwd>Neutrophils</kwd><kwd>Monocytes and macrophages</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China (National Science Foundation of China)</institution></institution-wrap></funding-source><award-id>82171800, 81871299, 82371822</award-id><principal-award-recipient><name name-style="western"><surname>Zheng</surname><given-names>Wenjie</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004826</institution-id><institution>Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)</institution></institution-wrap></funding-source><award-id>7232124</award-id><principal-award-recipient><name name-style="western"><surname>Zheng</surname><given-names>Wenjie</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>National High Level Hospital Clinical Research Funding [grant number 2022-PUMCH-C-008] and CAMS Innovation Fund for Medical Sciences [2023-I2M-C&amp;T-B-049].</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>CAMS Innovation Fund for Medical Sciences [2022-I2M-1-012], and Peking Union Medical College Hospital Talent Cultivation Program (UBJ10289-H.C.).</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Beh&#231;et&#8217;s disease (BD) is a chronic systemic vasculitis characterized by recurrent oral and genital ulcers, and potentially life-threatening manifestations<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, with heavy disease burden and high mortality. Current targeted therapies for BD are largely limited by its unknown etiology. Hence, uncovering the underlying mechanism of BD for developing novel targeted therapies is of great significance to improve the outcomes of BD.</p><p id="Par4">The pathogenesis of BD remains unclear. Current evidence suggests that it involves dysregulation of both innate and adaptive immunity, driven by genetic and environmental triggers. BD exhibits overlapping features with autoinflammatory diseases, characterized by recurrent acute inflammation mediated by innate immune cells overactivation, as well as autoimmune disorders marked by T-helper (Th) 1 and Th17 cell activation<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Notably, BD also aligns with MHC-I-opathies such as spondyloarthritis, sharing clinical and molecular mechanisms linked to aberrant MHC class I signaling<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Excessive infiltration of polymorphonuclear neutrophils (PMN) into inflamed tissues is a hallmark of BD, which is also known as &#8220;neutrophilic vasculitis&#8221;<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Activated PMN in BD release massive neutrophil extracellular traps (NETs) with enhanced pro-inflammatory effects, leading to IL-8 and TNF overproduction, and promote Th1 differentiation through macrophages<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, and further exacerbating vascular endothelial injury<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Conversely, monocytes and macrophages are activated and polarized under the BD immune microenvironment<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, and enhance neutrophil adhesion to endothelial cells<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Transcriptional analysis further suggests chemotaxis of BD PMN by monocytes via the CCR6-CCL20 pathway<sup><xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref></sup>.</p><p id="Par5">Exosomes are 30-130&#8201;nm extracellular vesicles (EV) with less heterogeneity, and serve as intercellular communication mediators<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> beyond cytokines, chemokines and NETs. Plasma exosomes and monocyte-derived exosomes potentially promote the inflammatory response of BD<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. PMN releases a major proportion of circulating exosomes due to abundant cell quantity. PMN exosomes exhibit versatile functions. PMN exosomes degrade extracellular matrix via integrin Mac-1 and neutrophil elastase (NE) to exacerbate alveolar destruction in chronic obstructive pulmonary disease (COPD)<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> and stimulate keratinocytes to express chemokines and proinflammatory cytokines<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> in psoriasis. In contrast, accumulating evidence suggests the immunoregulatory effects of PMN exosomes on innate immune system<sup><xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR23">23</xref></sup>, including attenuation of PMN chemotaxis<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, M2 macrophage polarization<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, and dendritic cell (DC) maturation<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p><p id="Par6">Given the crucial roles of PMN in BD pathogenesis and exosomes in cell-cell communication, this study investigates the abnormalities of BD PMN-derived exosomes, uncovering a reduction in miR-122-5p that targets IRF5, suppresses TLR4 signaling and IFN-&#946; autocrine, and downregulate macrophage activation. These findings not only elucidate a novel immunoregulatory mechanism mediated by PMN exosomes in BD pathogenesis, but also highlight the therapeutic potential of miR-122-5p/IRF5 pathway, which may extend to other autoimmune and autoinflammatory diseases.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Decreased and impaired immunoregulatory functions of PMN exosomes in BD</title><p id="Par7">The polarization of human monocyte-derived macrophages (HMDM) and THP-1 was assessed by flow cytometry analysis (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">1A, B</xref>). PMN exosomes were uniform in shape by TEM (Fig.&#160;<xref rid="Fig1" ref-type="fig">1A</xref>), expressing CD63 and TSG101, but not PCNA by western blotting (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">2A</xref>). BD and HC PMN exosomes were comparable in size (<italic toggle="yes">p</italic>&#8201;=&#8201;0.72, Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">2B</xref>); however, both unstimulated (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001) and LPS-stimulated BD PMN (p&#8201;=&#8201;0.0002) produced significantly lower levels of exosomes than HC PMN (Fig.&#160;<xref rid="Fig1" ref-type="fig">1B</xref>). Furthermore, LPS-stimulated active BD PMN secreted significantly lower levels of exosomes than inactive BD PMN (<italic toggle="yes">p</italic>&#8201;=&#8201;0.034, Fig.&#160;<xref rid="Fig1" ref-type="fig">1B</xref>), and BD PMN exosomes were negatively correlated with C-reactive protein (CRP) (r&#8201;=&#8201;&#8722;0.39, <italic toggle="yes">p</italic>&#8201;=&#8201;0.029, Fig.&#160;<xref rid="Fig1" ref-type="fig">1C</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>Impaired immunoregulatory effects in decreased BD PMN exosomes.</title><p><bold>A</bold> Transmission electron microscopy (TEM) analysis of the size and shape of exosomes derived from PMN of active BD, inactive BD and HC. Arrow indicates exosome derived from PMN. <bold>B</bold> Quantity of exosomes from unstimulated (left) or stimulated (right) PMN (active BD&#8201;=&#8201;23, inactive BD&#8201;=&#8201;9, HC&#8201;=&#8201;23). <bold>C</bold> Correlation analysis of BD PMN exosomes and CRP (<italic toggle="yes">n</italic>&#8201;=&#8201;32). <bold>D</bold> IL-6 and TNF production, (<bold>E</bold>) CD80 and (<bold>F</bold>) CD86 expression on HMDMs (<italic toggle="yes">n</italic>&#8201;=&#8201;10 for each group) stimulated with LPS and BD PMN exosomes (5ug/mL), HC PMN exosomes (5ug/mL) or PBS (blank control) for 9&#8201;h (<bold>D</bold>) and 4&#8201;h (<bold>E, F</bold>). One-way ANOVA tests (<bold>B</bold>) and two-way ANOVA (D-F) were used with adjusted two-tailed p-value using two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli were used. Pearson correlation analysis was used in (<bold>C</bold>). LPS, lipopolysaccharide; MFI, mean fluorescence intensity; CRP, C-reactive protein; HMDM, human monocyte-derived macrophages. N for all experiments were biological replicates. Data were summarized as mean&#8201;&#177;&#8201;standard deviation (SD). *, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; **, <italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.01; ***, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001; ****, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001; ns, not significant.</p></caption><graphic id="d33e482" position="float" orientation="portrait" xlink:href="41467_2025_63348_Fig1_HTML.jpg"/></fig></p><p id="Par8">We then treated HMDM with LPS-stimulated BD or HC PMN exosomes (5ug/ml) (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">2C</xref>). Given that TNF and IL-6 are crucial pro-inflammatory cytokines released by macrophages and play an essential role in BD pathogenesis<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>, we tested TNF and IL-6 production by macrophages treated with BD or HC PMN exosomes. Intriguingly, both BD and HC PMN exosomes suppressed IL-6, TNF, CD80 and CD86 expression in HMDM and THP-1 macrophages (Fig.&#160;<xref rid="Fig1" ref-type="fig">1D&#8211;F</xref>, and Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">2D</xref>), but BD PMN exosomes suppressed less IL-6 (<italic toggle="yes">p</italic>&#8201;=&#8201;0.0011), TNF (<italic toggle="yes">p</italic>&#8201;=&#8201;0.0486), CD80 (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001) and CD86 (<italic toggle="yes">p</italic>&#8201;=&#8201;0.0056) than HC PMN exosomes. Taken together, these data indicated that BD PMN produced less quantity and quality of immunoregulatory exosomes, which potentially contributed to macrophage overactivation in BD.</p></sec><sec id="Sec4"><title>Downregulated miR-122-5p in BD PMN exosomes dampens the immunoregulatory property</title><p id="Par9">Considering the&#160;close relationship between exosome and epigenetics, we performed microRNA (miRNA) sequencing on 4 paired BD and HC PMN exosomes to explore the mechanism of dampened immunoregulatory BD PMN exosomes. The miRNA profiling of BD PMN exosomes showed a transcriptionally inactive gene signature (Fig.&#160;<xref rid="Fig2" ref-type="fig">2A</xref>), with 6 downregulated and 5 upregulated miRNAs, including 3 unconservative miRNAs (Fig.&#160;<xref rid="Fig2" ref-type="fig">2B</xref>, and Supplementary Data&#160;<xref rid="MOESM3" ref-type="media">1</xref>). Given decreased exosomes in BD PMN, we focused on the downregulated miRNAs. KEGG enrichment of downstream targets predicted by miRanda suggested potential immunoregulatory function of miR-122-5p, miR-134-5p and miR-6501-5p on inflammatory pathways including TNF signaling pathway, Toll-like receptor (TLR) signaling pathway, chemokine signaling pathway and viral infection-related pathways (Fig.&#160;<xref rid="Fig2" ref-type="fig">2C</xref>, and Supplementary Data&#160;<xref rid="MOESM4" ref-type="media">2</xref>). In contrast, other miRNAs that have been reported to be associated with BD (for example, miR-146a<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup> and miR-155<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>, etc.) were either undetectable or not&#160;differentially expressed in our BD vs. HC PMN exosome dataset (Fig.&#160;<xref rid="Fig2" ref-type="fig">2D</xref>).<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>MicroRNA sequencing of four paired BD and HC PMN exosomes.</title><p><bold>A</bold> Volcano plot and (<bold>B</bold>) heatmap of differentially expressed exosomal miRNAs between BD and HC PMN exosomes (<italic toggle="yes">n</italic>&#8201;=&#8201;4 for each group). <bold>C</bold> KEGG enrichment of downstream targets of downregulated differentially expressed exosomal miRNAs predicted by miRanda. <bold>D</bold> The expression level of BD-associated miRNA in our miRNA sequencing dataset (<italic toggle="yes">n</italic>&#8201;=&#8201;4 for each group). The significance of the C diagram was performed by function <italic toggle="yes">enrichKEGG</italic> in the R package ClusterProfiler. Data were summarized as mean&#8201;&#177;&#8201;SD and Negative binomial distribution was performed using R package DESeq2 in D.</p></caption><graphic id="d33e580" position="float" orientation="portrait" xlink:href="41467_2025_63348_Fig2_HTML.jpg"/></fig></p><p id="Par10">We further confirmed that miR-122-5p, miR-134-5p and miR-6501-5p inhibited IL-6 and (or) TNF production in both HMDM (Fig.&#160;<xref rid="Fig3" ref-type="fig">3A, B</xref>) and THP-1 macrophages (Fig.&#160;<xref rid="Fig3" ref-type="fig">3C, D</xref>). However, only inhibition of miR-122-5p, the highest differentially expressed miRNA (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>B, D, Supplementary Data&#160;<xref rid="MOESM3" ref-type="media">1</xref>), reversed the immunoregulatory effects of PMN exosomes (IL-6: <italic toggle="yes">p</italic>&#8201;=&#8201;0.0042; TNF: <italic toggle="yes">p</italic>&#8201;=&#8201;0.0012, Fig.&#160;<xref rid="Fig3" ref-type="fig">3E</xref>). Additionally, we assessed the expression levels of miR-122-5p in PMN exosomes from active and inactive BD patients. The miR-122-5p level was significantly lower in PMN exosomes from active BD compared to those from inactive BD or HC (Fig.&#160;<xref rid="Fig3" ref-type="fig">3F</xref>). Of note, the miR-122-5p level in PMN exosomes from active BD patients increased upon achieving remission (Fig.&#160;<xref rid="Fig3" ref-type="fig">3F</xref>). Furthermore, miR-122-5p levels in PMN exosomes were negatively correlated with clinical disease activity indicators, including CRP and ESR (Fig.&#160;<xref rid="Fig3" ref-type="fig">3G</xref>).<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title>Downregulated miR-122-5p in BD PMN exosomes dampens the immunoregulatory properties of macrophages.</title><p><bold>A</bold>, <bold>B</bold> The secretion (<bold>A</bold>, <italic toggle="yes">n</italic>&#8201;=&#8201;10 for each group) and mRNA expression (<bold>B</bold>) <italic toggle="yes">n</italic>&#8201;=&#8201;6 for each group) level of IL-6 and TNF from HMDM transfected with microRNA mimics. <bold>C</bold>, <bold>D</bold> IL-6 and TNF production in LPS-stimulated THP-1 macrophages transfected with indicated miRNA mimics (<bold>C</bold>) <italic toggle="yes">n</italic>&#8201;=&#8201;10 for each group; <bold>D</bold>, <italic toggle="yes">n&#8201;</italic>=&#8201;6 for each group). <bold>E</bold> IL-6 and TNF secretion in LPS-stimulated THP-1 macrophages treated with PMN exosomes (5ug/mL) and indicated miRNA inhibitors (<italic toggle="yes">n</italic>&#8201;=&#8201;8 for each group). <bold>F</bold> The relative expression level of miR-122-5p in PMN-derived exosomes from HC (<italic toggle="yes">n</italic>&#8201;=&#8201;16 for each group) and patients with active/inactive BD (<italic toggle="yes">n&#8201;</italic>=&#8201;16 for each group), with longitudinal data from paired cases of active BD to remission (<italic toggle="yes">n</italic>&#8201;=&#8201;8). <bold>G</bold> Correlations between the relative expression level of miR122-5p in BD PMN-derived exosomes and BD clinical disease activity indicators, CRP and ESR (<italic toggle="yes">n</italic>&#8201;=&#8201;32). One-way ANOVA tests were used in (<bold>A</bold>&#8211;<bold>F</bold>) with adjusted two-tailed p-value using two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli. Two-tailed paired t-test was used in (<bold>F</bold>) and Pearson correlation analysis was used in (<bold>G</bold>). N for all experiments were biological replicates. CRP, C-reactive protein; ESR, Erythrocyte Sedimentation Rate; Data were summarized as mean&#8201;&#177;&#8201;SD. *, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; **, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; ***, <italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.001; ****, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001; ns, not significant.</p></caption><graphic id="d33e709" position="float" orientation="portrait" xlink:href="41467_2025_63348_Fig3_HTML.jpg"/></fig></p><p id="Par11">To further investigate the regulation of macrophage activation by miR-122-5p in vivo, we peritoneally injected miR-122-5p agomir into mice. miR-122-5p agomir significantly inhibited TNF (p&#8201;=&#8201;0.0359), IL6 (p&#8201;=&#8201;0.0486) and CD86 (p&#8201;=&#8201;0.0216) expression in mouse peritoneal macrophages (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">3</xref>), and a trend towards decreasing IRF5 expression levels. Collectively, our data suggested that decreased miR-122-5p in BD PMN exosomes played a key role in dampened immunoregulatory effects on macrophages.</p></sec><sec id="Sec5"><title>Exosomal miR-122-5p targets IRF5 and inhibits macrophage inflammation</title><p id="Par12">To gain insight into the mechanism of immunoregulatory effects of exosomal miR-122-5p, we performed RNA-sequencing on LPS-stimulated THP-1 macrophages transfected with miR-122-5p or control miRNA mimics. PCA analysis clearly distinguished two groups (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">4A</xref>), and mRNA profiling showed a distinct transcriptionally inactive gene signature in miR-122-5p-transfected macrophages, with 779 upregulated and 1037 downregulated differentially expressed protein-coding genes (DEGs), corresponding to miRNA&#8217;s negative regulation on mRNAs (Fig.&#160;<xref rid="Fig4" ref-type="fig">4A</xref>, and Supplementary Data&#160;<xref rid="MOESM5" ref-type="media">3</xref>). GSEA of transcriptional profiles illustrated significantly downregulated inflammatory immune responses in miR-122-5p-transfected macrophages, including TLR, TNF, NF-&#954;B and JAK-STAT pathways (Fig.&#160;<xref rid="Fig4" ref-type="fig">4B, C</xref>, and Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">4B, C</xref>, Supplementary Data&#160;<xref rid="MOESM6" ref-type="media">4</xref>). Cytokine profile also showed an anti-inflammatory pattern (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">4D</xref>), noted by decreased proinflammatory cytokines including IFN-&#946;, TNFSF10, IL-6 and TNF, and increased anti-inflammatory cytokines including TGF-&#946;.<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><title>Transcriptional analysis of miR-122-5p-transfected THP-1 macrophages.</title><p><bold>A</bold> Volcano plot of differentially expressed genes between miR-122-5p-transfected and control THP-1 macrophages (n&#8201;=&#8201;6 for each group). <bold>B</bold> Heatmap of TLR signaling pathway gene set expression. <bold>C</bold> GSEA of transcriptional profiles of miR-122-5p-transfected THP-1 macrophages. <bold>D</bold> Circosplot (left) and dotplot (right) of the regulatory network of miR-122-5p, predicted target TFs, predicted target genes and enriched pathways. The significance of the C and D diagram was performed by function <italic toggle="yes">GSEA</italic> and <italic toggle="yes">enrichKEGG</italic> in the R package ClusterProfiler, respectively.</p></caption><graphic id="d33e766" position="float" orientation="portrait" xlink:href="41467_2025_63348_Fig4_HTML.jpg"/></fig></p><p id="Par13">We next performed transcription factor (TF) co-regulatory network analysis to explore the key regulatory target regulated by miR-122-5p. miR-122-5p-regulated TFs were filtered by miRanda from DEGs, and the relevant downstream regulated DEGs were predicted by ChEA3 database, and further filtered by Pearson correlation coefficient analysis between TFs and DEGs, which showed that decreased transcription factor IRF5 together with its downstream regulated genes was the crucial target of miR-122-5p (Fig.&#160;<xref rid="Fig4" ref-type="fig">4D</xref>). IRF5 is the key TF controlling M1 polarization, which was closely correlated with our phenotype according to KEGG pathway (Fig.&#160;<xref rid="Fig4" ref-type="fig">4D</xref> and Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">4C</xref>). miRanda, TargetScan and miRWalk database predicted IRF5 as miR-122-5p target (Fig.&#160;<xref rid="Fig5" ref-type="fig">5A</xref> and Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">5A</xref>). Furthermore, dual-luciferase reporter assay verified that miR-122-5p directly bound to IRF5 3&#8217;UTR (relative LUC activity: <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001, Fig.&#160;<xref rid="Fig5" ref-type="fig">5B</xref>) and downregulated IRF5 expression in both mRNA (p&#8201;&lt;&#8201;0.0001, Fig.&#160;<xref rid="Fig5" ref-type="fig">5C</xref>) and protein (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001, Fig.&#160;<xref rid="Fig5" ref-type="fig">5D</xref>) levels. Consistently, IRF5 silencing reduced IL-6, TNF, CD80 and CD86 expression in both HMDM (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">5B</xref>) and THP-1 macrophages (Fig.&#160;<xref rid="Fig5" ref-type="fig">5E&#8211;G</xref>); while IRF5 overexpression restored TNF and IL-6 expression attenuated by miR-122-5p in both HMDM (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">5C</xref>) and THP-1 macrophages (Fig.&#160;<xref rid="Fig5" ref-type="fig">5H, I</xref>). Collectively, our data supported that miR-122-5p in PMN exosomes directly downregulated IRF5 and inhibited TLR4 pathway in macrophages, which was impaired in BD PMN exosomes.<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><title>Exosomal miR-122-5p inhibits macrophage activation&#160;by targeting IRF5.</title><p><bold>A</bold> Sequence alignment of miR-122-5p, 3&#8217;UTR of IRF5 and mutant 3&#8217;UTR of IRF5. <bold>B</bold> Dual-luciferase reporter assay of miR-122-5p and IRF5 (<italic toggle="yes">n</italic>&#8201;=&#8201;8 for each group) in HEK293T cells. <bold>C</bold>, <bold>D</bold> RT-qPCR (<bold>C</bold>) and Western blot (<bold>D</bold>) (<italic toggle="yes">n</italic>&#8201;=&#8201;6 for each group) analysis of IRF5 expression in macrophages transfected with miR-122-5p or control miRNA. Representative of western blot result was shown in left panel in (<bold>D</bold>). <bold>E</bold>, <bold>F</bold> IL-6 (<bold>E</bold>) and TNF (<bold>F</bold>) production in IRF5-silenced THP-1 macrophages. mRNA level (left panel, <italic toggle="yes">n</italic>&#8201;=&#8201;8 for each group) and protein level (right panel, <italic toggle="yes">n</italic>&#8201;=&#8201;10 for each group) were measured after 4-h and 9-h LPS-stimulation, respectively. (<bold>G</bold>) CD80 and CD86 expression in IRF5-silenced THP-1 macrophages stimulated with LPS for 4&#8201;h (<italic toggle="yes">n</italic>&#8201;=&#8201;6 for each group). <bold>H, I</bold> IL-6 (<bold>H</bold>) and TNF (<bold>I</bold>) production in THP-1 macrophages with co-transfection of miR-122-5p mimic and (or) IRF5-plasmid. mRNA level (left panel, <italic toggle="yes">n</italic>&#8201;=&#8201;8 for each group) and protein level (right panel, <italic toggle="yes">n</italic>&#8201;=&#8201;10 for each group) were measured after 4-h and 9-h LPS-stimulation, respectively. Two-tailed independent t-test (<bold>B&#8211;G</bold>) and One-way ANOVA tests (<bold>H</bold>, <bold>I</bold>) with adjusted two-tailed <italic toggle="yes">p</italic> value using two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli were applied. NES, normalized enrichment score; UTR, untranslated region. N for all experiments were biological replicates. Data were summarized as mean&#8201;&#177;&#8201;SD. *, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; **, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; ***, <italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.001; ****, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001.</p></caption><graphic id="d33e914" position="float" orientation="portrait" xlink:href="41467_2025_63348_Fig5_HTML.jpg"/></fig></p></sec><sec id="Sec6"><title>Exosomal miR-122-5p suppresses IFN-&#946; autocrine and inhibits macrophage inflammation</title><p id="Par14">We also noted IFN-&#946; as the most downregulated cytokine (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">4D</xref>) as well as dampened JAK-STAT pathways (Fig.&#160;<xref rid="Fig4" ref-type="fig">4C</xref>) in miR-122-5p-transfected macrophages, suggesting inhibited IFN-&#946; autocrine by miR-122-5p. Both miR-122-5p mimics (supernatant: <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001; relative mRNA expression: p&#8201;&lt;&#8201;0.0001) and IRF5 silencing (supernatant: <italic toggle="yes">p</italic>&#8201;=&#8201;0.0019; relative mRNA expression: <italic toggle="yes">p</italic>&#8201;=&#8201;0.0006) downregulated IFN-&#946; production in macrophages (Fig.&#160;<xref rid="Fig6" ref-type="fig">6A, B</xref>), while restoration of IRF5 by plasmid transfection upregulated IFN-&#946; production (Fig.&#160;<xref rid="Fig6" ref-type="fig">6C</xref>), supporting IRF5 induced transcription of type I IFN genes<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Furthermore, the attenuated TNF and IL-6 by miR-122-5p was restored by exogenous IFN-&#946; (Fig.&#160;<xref rid="Fig6" ref-type="fig">6D, E</xref>) in macrophages. Additionally, STAT1, the IFN-&#946; signaling adaptor, was downregulated (Supplementary Data&#160;<xref rid="MOESM5" ref-type="media">3</xref>, Fig.&#160;<xref rid="Fig7" ref-type="fig">7A</xref>), and STAT1 phosphorylation was inhibited by miR-122-5p and restored by exogenous IFN-&#946; (Fig.&#160;<xref rid="Fig7" ref-type="fig">7B</xref>). STAT1 inhibition dampened IFN-&#946;-induced TNF and IL-6 production in macrophages (Fig.&#160;<xref rid="Fig7" ref-type="fig">7C-D</xref>). Finally, restoration of IFN-&#946; increased STAT1 (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001, Fig.&#160;<xref rid="Fig7" ref-type="fig">7E</xref>) and IRF5 expression (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001, Fig.&#160;<xref rid="Fig7" ref-type="fig">7F</xref>), suggesting a positive feedback loop of IFN-&#946; during macrophage activation. Altogether, our results expanded the mechanism that miR-122-5p/IRF5 axis also suppressed IFN-&#946; autocrine, and inhibited macrophage activation (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">6</xref>).<fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><title>Exosomal miR-122-5p inhibits macrophages by suppressing IFN-&#946; autocrine.</title><p><bold>A</bold> IFN-&#946; production in miR-122-5p-transfected THP-1 macrophages stimulated with LPS for 4&#8201;h (left, mRNA level, <italic toggle="yes">n</italic>&#8201;=&#8201;8 for each group) and 9&#8201;h (right, protein level, <italic toggle="yes">n</italic>&#8201;=&#8201;7 for each group), respectively. <bold>B</bold> IFN-&#946; production in IRF5-silenced THP-1 macrophages stimulated with LPS for 4&#8201;h (left, mRNA level, <italic toggle="yes">n</italic>&#8201;=&#8201;6 for each group) and 9&#8201;h (right, protein level, <italic toggle="yes">n</italic>&#8201;=&#8201;7 for each group), respectively. <bold>C</bold> IFN-&#946; production in THP-1 macrophages with co-transfection of miR-122-5p mimic and (or) IRF5-plasmid. mRNA level (<italic toggle="yes">n</italic>&#8201;=&#8201;9 for each group) and protein level (<italic toggle="yes">n</italic>&#8201;=&#8201;10 for each group) were measured after 4-h and 9-h LPS-stimulation, respectively. <bold>D</bold>, <bold>E</bold> TNF (<bold>D</bold>) and IL-6 (<bold>E</bold>) production in LPS-stimulated THP-1 macrophages transfected with or without miR-122-5p mimics, supplemented with or without stimulation of LPS and (or) IFN-&#946; (500&#8201;U/mL). mRNA level (<italic toggle="yes">n</italic>&#8201;=&#8201;6 for each group) and protein level (<italic toggle="yes">n</italic>&#8201;=&#8201;10 for each group) were measured after 4-h and 9-h LPS-stimulation, respectively. Two-tailed independent t-test (<bold>A</bold>, <bold>B</bold>) and One-way ANOVA tests (<bold>C&#8211;E</bold>) with adjusted two-tailed <italic toggle="yes">p</italic> value using two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli were applied. Data were summarized as mean&#8201;&#177;&#8201;SD. * <italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.05; **, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; ***, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001; ****, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001.</p></caption><graphic id="d33e1056" position="float" orientation="portrait" xlink:href="41467_2025_63348_Fig6_HTML.jpg"/></fig><fig id="Fig7" position="float" orientation="portrait"><label>Fig. 7</label><caption><title>STAT1 inhibition by miR-122-5p dampened IFN-&#946;-induced macrophage hyperactivation.</title><p><bold>A</bold> mRNA of STAT1 expression in miR-122-5p-transfected THP-1 macrophages stimulated with LPS for 4&#8201;h (<italic toggle="yes">n&#8201;</italic>=&#8201;8 for each group). <bold>B</bold> Western blot analysis of STAT1 phosphorylation in THP-1 macrophages transfected with or without miR-122-5p mimics, supplemented with IFN-&#946; (500&#8201;U/mL). <bold>C</bold>, <bold>D</bold> TNF (<bold>C</bold>) and IL-6 (<bold>D</bold>) production in LPS-stimulated THP-1 macrophages transfected with or without si-STAT1, supplemented with or without IFN-&#946;. The mRNA level (<italic toggle="yes">n</italic>&#8201;=&#8201;6 for each group) and protein level (<italic toggle="yes">n&#8201;</italic>=&#8201;10 for each group) were measured after 4-h and 9-h LPS-stimulation, respectively. <bold>E</bold> STAT1 expression in LPS-stimulated THP-1 macrophages transfected with or without miR-122-5p, supplemented with or without IFN-&#946; (<italic toggle="yes">n</italic>&#8201;=&#8201;6 for each group). <bold>F</bold> IRF5 expression in LPS-stimulated THP-1 macrophages transfected with or without miR-122-5p, supplemented with or without IFN-&#946; (n&#8201;=&#8201;6 for each group). Two-tailed independent-samples t-tests were used in A. One-way ANOVA tests were used in C-F with adjusted two-tailed p-value using two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli were used. N for all experiments were biological replicates. Data were summarized as mean&#8201;&#177;&#8201;SD. *, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; **, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; ***, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001; ****, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001; ns, not significant.</p></caption><graphic id="d33e1114" position="float" orientation="portrait" xlink:href="41467_2025_63348_Fig7_HTML.jpg"/></fig></p></sec></sec><sec id="Sec7" sec-type="discussion"><title>Discussion</title><p id="Par15">In this study, we found that BD PMN released less exosomes which were negatively correlated with BD inflammation. Moreover, PMN exosomes suppressed macrophages to express pro-inflammatory cytokines and costimulatory molecules, which was significantly impaired in BD PMN exosomes. Mechanistically, BD PMN exosomes contain lower levels of miR-122-5p, which targeted IRF5 and subsequently suppressed TNF, IL-6 as well as IFN-&#946; autocrine, highlighting a dysregulated immunoregulatory mechanism by PMN exosomes in BD pathogenesis.</p><p id="Par16">PMN are essential inflammatory immune cells in BD, which promote inflammation through pro-inflammatory cytokines, NETs and secretory granules<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. Although PMN dominate the early stage of inflammation through rapid and potent immune activation, these cells are also reported to contribute to the resolution of inflammation, the aberrance of which leads to persistent immune responses and chronic inflammation<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. In lupus and experimental autoimmune encephalomyelitis model, PMN inhibit T cell proliferation via Mac-1, H<sub>2</sub>O<sub>2</sub>, NO and arginase I<sup><xref ref-type="bibr" rid="CR37">37</xref>&#8211;<xref ref-type="bibr" rid="CR39">39</xref></sup>. Intriguingly, we found that PMN exosomes also had immunoregulatory potentials. PMN extracellular vesicles inhibit chemotaxis, adhesion and migration of PMN to endothelial cells through annexin 1<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>, and suppress maturation and pro-inflammatory functions of immature monocyte-derived DCs via phosphatidylserine<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. TNF-stimulated PMN exosomes inhibit M1 polarization and promote TGF-&#946; secretion in macrophages<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>, and inhibit pro-inflammatory cytokine production in synoviocytes in rheumatoid arthritis (RA)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. In gout, PMN microvesicles induced by C5a suppress C5a-primed NLRP3 inflammasome activation and trigger TGF-&#946; secretion<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Hence, PMN exosomes may serve as a &#8216;brake&#8217; of inflammation in macrophages. Defective BD PMN exosomes downregulated suppression of IL-6 and TNF, and facilitated macrophage activation in BD. Given that PMN exosomes are characterized by low immunogenicity, prolonged circulation, and deep penetration<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>, PMN exosomes may provide promising therapy for BD.</p><p id="Par17">Exosomal miR-122-5p suppressed TLR axis in macrophages. Previous studies report that miR-122-5p regulates innate immune response through TLR/NF-&#954;B axis, alleviates intestinal epithelial injury by targeting NOD2 and SBP1 in Crohn&#8217;s disease<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>, attenuates inflammatory response and ROS production by targeting CPEB1 in spinal cord injury model<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, downregulates inflammatory responses by targeting TLR4 in hepatoma cells and hepatic stellate cells<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, and inhibits NF-&#954;B and IRF3 pathways in teleost fish<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, suggesting a conservative immunoregulatory function of miR-122-5p across species. Importantly, TLR/NF-&#954;B axis promotes transcription of miR-122-5p precursor miR-122HG<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Therefore, miR-122-5p serves as negative feedback to inflammatory response, which is defective in BD PMN exosomes and induces impaired suppression of macrophages.</p><p id="Par18">miR-122-5p also regulates the&#160;innate immune response through JAK-STAT1 signaling activated by IFN-&#946; in macrophages. miR-122-5p modulates interferon/interferon-stimulated response element axis in HCV infection<sup><xref ref-type="bibr" rid="CR49">49</xref>,<xref ref-type="bibr" rid="CR50">50</xref></sup>. Autocrine of IFN-&#946; is enhanced during TLR activation and promotes TLR-induced inflammation<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, such as MCP-1 production by macrophages<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> and IL-12 secretion by DCs<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Additionally, miR-122-5p promotes mitochondrial oxidative phosphorylation (OXPHOS) through overproduction of mtDNA-encoded proteins<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, and inhibits glycolysis by targeting <italic toggle="yes">PKM2</italic><sup><xref ref-type="bibr" rid="CR55">55</xref></sup> and <italic toggle="yes">ALDOA</italic><sup><xref ref-type="bibr" rid="CR56">56</xref></sup>, which are reversed during M1 macrophage polarization<sup><xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. Consistently, we found that miR-122-5p enhanced oxidative phosphorylation, suggesting that miR-122-5p might inhibit macrophage M1 polarization and inflammation via metabolic pathways. Of note, neutrophil exosomal miR-122-5p regulates apoptosis and proliferation of endothelial cells<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Taken together, miR-122-5p regulates macrophage activation and inflammation through multiple pathways, and delivering miR-122-5p through exosomes might offer a new target-based therapy for BD.</p><p id="Par19">Our study had limitations. First, we focused on miRNAs in PMN exosomes, but other exosome components such as lncRNA, small molecule metabolites might also have immunoregulatory properties. Second, we investigated the immunoregulatory mechanism of PMN exosomes on macrophages, and other immune cells such as Th1 and Th17 cells are potentially regulated by PMN exosomes. Third, we showed that exosomal miR-122-5p suppressed macrophages in vitro, and whether the suppression is evident in BD patients in vivo remains elusive. Fourth, the mechanism of decreased exosomes in BD PMN remains unknown; we analyzed our transcriptome dataset (<ext-link ext-link-type="pmc:entrez-geo" xlink:href="GSE205867">GSE205867</ext-link>)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> but didn&#8217;t find clues. We speculated proteomics approach might provide new insights for short-lived neutrophils.</p><p id="Par20">In conclusion, our study demonstrated that BD PMN exosomes were decreased in both quantity and miR-122-5p, which impaired the immunoregulatory potentials on macrophages through targeting IRF5 and suppressing IFN-&#946; autocrine. Defective BD PMN exosomes suggested a new interaction mechanism between PMN and macrophages and played a role in BD pathogenesis.</p></sec><sec id="Sec8"><title>Methods</title><sec id="Sec9"><title>Sample collection</title><p id="Par21">Peripheral blood samples were collected from active BD patients (<italic toggle="yes">n</italic>&#8201;&#8201;=&#8201;&#8201;39), inactive BD patients (<italic toggle="yes">n</italic>&#8201;&#8201;=&#8201;&#8201;25), and gender- and age-matched healthy controls (HC) (<italic toggle="yes">n</italic>&#8201;=&#8201;39) enrolled at Peking Union Medical College Hospital (PUMCH) between June 2019 and January 2025 (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). For miRNA sequencing of PMN exosomes, peripheral blood samples were collected from 4 treatment-na&#239;ve active BD patients and gender- and age-matched HC (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). All BD patients fulfilled the International Criteria for BD (ICBD)<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. BD disease activity was assessed using the BD Current Activity Form 2006 (BDCAF 2006). The study was approved by the PUMCH Ethical Committee (I-24PJ1059), and written informed consent was obtained from all subjects in accordance with the Declaration of Helsinki.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Demographics and characteristics of BD patients and healthy controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1"/><th colspan="3" rowspan="1">Exosomal Quantification Cohort</th><th colspan="2" rowspan="1">Exosomal miRNA Sequencing Cohort</th><th colspan="3" rowspan="1">MiR122-5p Quantification Cohort</th></tr><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">Active BD (n&#8201;=&#8201;23)</th><th colspan="1" rowspan="1">Inactive BD (<italic toggle="yes">n&#8201;</italic>=&#8201;9)</th><th colspan="1" rowspan="1">HC (<italic toggle="yes">n</italic>&#8201;=&#8201;23)</th><th colspan="1" rowspan="1">BD (<italic toggle="yes">n</italic>&#8201;=&#8201;4)</th><th colspan="1" rowspan="1">HC (<italic toggle="yes">n</italic>&#8201;=&#8201;4)</th><th colspan="1" rowspan="1">Active BD (<italic toggle="yes">n</italic>&#8201;=&#8201;16)</th><th colspan="1" rowspan="1">Inactive BD (<italic toggle="yes">n</italic>&#8201;=&#8201;16)</th><th colspan="1" rowspan="1">HC (<italic toggle="yes">n</italic>&#8201;=&#8201;16)</th></tr></thead><tbody><tr><td colspan="2" rowspan="1">Age (mean&#8201;&#177;&#8201;SD, year)</td><td colspan="1" rowspan="1">36.3&#8201;&#177;&#8201;14.1</td><td colspan="1" rowspan="1">35.44&#8201;&#177;&#8201;9.22</td><td colspan="1" rowspan="1">40&#8201;&#177;&#8201;10.2</td><td colspan="1" rowspan="1">36.75&#8201;&#177;&#8201;3.59</td><td colspan="1" rowspan="1">36.75&#8201;&#177;&#8201;3.59</td><td colspan="1" rowspan="1">40.13&#8201;&#177;&#8201;11.57</td><td colspan="1" rowspan="1">39.5&#8201;&#177;&#8201;10.34</td><td colspan="1" rowspan="1">34.69&#8201;&#177;&#8201;9.19</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex</td><td align="left" colspan="1" rowspan="1">Male</td><td align="left" colspan="1" rowspan="1">17 (73.9%)</td><td align="left" colspan="1" rowspan="1">6 (66.7%)</td><td align="left" colspan="1" rowspan="1">17 (73.9%)</td><td align="left" colspan="1" rowspan="1">3 (75%)</td><td align="left" colspan="1" rowspan="1">3 (75%)</td><td align="left" colspan="1" rowspan="1">7 (43.75%)</td><td align="left" colspan="1" rowspan="1">7 (43.75%)</td><td align="left" colspan="1" rowspan="1">7 (43.75%)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Female</td><td align="left" colspan="1" rowspan="1">6 (26.1%)</td><td align="left" colspan="1" rowspan="1">3 (33.3%)</td><td align="left" colspan="1" rowspan="1">6 (26.1%)</td><td align="left" colspan="1" rowspan="1">1 (25%)</td><td align="left" colspan="1" rowspan="1">1 (25%)</td><td align="left" colspan="1" rowspan="1">9 (56.25%)</td><td align="left" colspan="1" rowspan="1">9 (56.25%)</td><td align="left" colspan="1" rowspan="1">9 (56.25%)</td></tr><tr><td colspan="10" rowspan="1">Clinical features</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Oral ulcer</td><td align="left" colspan="1" rowspan="1">23 (100%)</td><td align="left" colspan="1" rowspan="1">9 (100%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">4 (100%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">16 (100%)</td><td align="left" colspan="1" rowspan="1">16 (100%)</td><td align="left" colspan="1" rowspan="1">/</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Genital ulcer</td><td align="left" colspan="1" rowspan="1">16 (69.6%)</td><td align="left" colspan="1" rowspan="1">2 (22.2%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">3 (75%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">15 (93.75%)</td><td align="left" colspan="1" rowspan="1">10 (62.5)</td><td align="left" colspan="1" rowspan="1">/</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Gastrointestinal involvement</td><td align="left" colspan="1" rowspan="1">4 (17.4%)</td><td align="left" colspan="1" rowspan="1">2 (22.2%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">0 (0%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">5 (31.25%)</td><td align="left" colspan="1" rowspan="1">4 (25%)</td><td align="left" colspan="1" rowspan="1">/</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Erythema nodosum</td><td align="left" colspan="1" rowspan="1">14 (60.9%)</td><td align="left" colspan="1" rowspan="1">1 (11.1%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">2 (50%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">7 (43.75%)</td><td align="left" colspan="1" rowspan="1">4 (25%)</td><td align="left" colspan="1" rowspan="1">/</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Ocular involvement</td><td align="left" colspan="1" rowspan="1">2 (8.7%)</td><td align="left" colspan="1" rowspan="1">0 (0%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">1 (25%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">/</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Vascular involvement</td><td align="left" colspan="1" rowspan="1">7 (30.4%)</td><td align="left" colspan="1" rowspan="1">6 (66.7%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">2 (50%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">7 (43.75%)</td><td align="left" colspan="1" rowspan="1">7 (43.75%)</td><td align="left" colspan="1" rowspan="1">/</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">CNS involvement</td><td align="left" colspan="1" rowspan="1">0 (0%)</td><td align="left" colspan="1" rowspan="1">1 (11.1%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">0 (0%)</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">1 (6.25%)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">/</td></tr><tr><td colspan="2" rowspan="1">BDCAF (median)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">/</td></tr><tr><td colspan="2" rowspan="1">ESR (mean&#8201;&#177;&#8201;SD, mm/h)</td><td colspan="1" rowspan="1">30.65&#8201;&#177;&#8201;24.13</td><td colspan="1" rowspan="1">5.25&#8201;&#177;&#8201;5.09</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">25.5&#8201;&#177;&#8201;7.37</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">26.25&#8201;&#177;&#8201;15.75</td><td colspan="1" rowspan="1">5.69&#8201;&#177;&#8201;4.58</td><td colspan="1" rowspan="1">/</td></tr><tr><td colspan="2" rowspan="1">CRP (mean&#8201;&#177;&#8201;SD, mg/L)</td><td colspan="1" rowspan="1">22.16&#8201;&#177;&#8201;20.58</td><td colspan="1" rowspan="1">2.21&#8201;&#177;&#8201;2.59</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">21.06&#8201;&#177;&#8201;20.67</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">38.57&#8201;&#177;&#8201;40.06</td><td colspan="1" rowspan="1">5.68&#8201;&#177;&#8201;4.58</td><td colspan="1" rowspan="1">/</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec10"><title>Cell isolation and culture</title><p id="Par22">Peripheral blood samples were collected, and peripheral blood mononuclear cells (PBMCs) were extracted from whole blood by density gradient centrifugation using Human Lymphocyte Separation Medium according to the manufacturer&#8217;s instructions (7111011, DAKEWE, SZ, China). PMN were isolated by erythrocyte lysis with subsequent centrifugation, as previously described<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. The Neutrophil purity was checked by flow cytometry using CD11b and CD16 staining. Density gradient-isolated PBMC and PMN were maintained in complete DMEM (12491, Gibco, New York, USA) and X-VIVO 15 (BE02-054Q, LONZA), respectively. Anti-CD14 magnetic-isolated monocytes (130-050-201, Miltenyi Biotech, Bergisch Gladbach, Germany) were seeded in complete DMEM supplemented with 50ng/mL M-CSF (m6518, Sigma, Saint Louis, Missouri, USA) for 7 days to differentiate into HMDM. THP-1 cells were purchased from Procell Biotechnology Co., Ltd, China (CL-0233) with authentication by STR analysis. THP-1 cells were stimulated with 50&#8201;ng/ml PMA (P1585, Sigma) in complete DMEM for 24&#8201;h to differentiate into adherent macrophages, which were rested for 24&#8201;h until use. The polarization of HMDM and THP-1 was assessed by flow cytometry analysis (Supplementary Fig.&#160;<xref rid="MOESM1" ref-type="media">1</xref>).</p></sec><sec id="Sec11"><title>Exosome isolation and identification</title><p id="Par23">PMN (3*10<sup>6</sup>/ml) were stimulated by 100&#8201;ng/ml LPS (437620, Sigma) or blank control (PBS) in X-VIVO for 24&#8201;h. The supernatant was centrifuged at 2000g, 30&#8201;min to remove cells and debris, then 20&#8201;ml supernatant was mixed with 10&#8201;ml Total Exosome Isolation reagent (4478359, Life Technologies Corporation, Carlsbad, California, USA) and incubated at 4&#176;C overnight, which was centrifuged at 10,000&#8201;g for 1&#8201;h to obtain the exosomes. Transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA) were employed to identify exosomes. Western Blot of positive markers TSG101 (ab134045, Abcam, Cambridge, UK) and CD63 (ab125011, Abcam) and negative exosome marker PCNA (HRP-60097, Proteintech, China) were performed.</p></sec><sec id="Sec12"><title>Enzyme-linked immunosorbent assay (ELISA)</title><p id="Par24">Supernatant TNF and IL-6 of HMDM or THP-1 macrophages stimulated with LPS and PMN exosomes, and supernatant TNF, IL-6 and IFN-&#946; of HMDM or THP-1 macrophages stimulated with LPS and miRNA mimic/inhibitors or siRNA, were measured. Supernatant exosomes from PMN stimulated with or without LPS were measured. Quantification of supernatant exosomes (Abcam), IL-6 (430504, Biolegend, California, USA), TNF (430201, Biolegend) and IFN-&#946; (EK1511, Sabbiotech, Greenbelt, Maryland, USA) were conducted in duplicate using a Multiskan FC Photometer (Thermo, USA) according to the manufacture&#8217;s instructions.</p></sec><sec id="Sec13"><title>RNA extraction and reverse transcription-quantitative PCR (RT-qPCR)</title><p id="Par25">Total RNA was extracted from macrophages using Trizol (15596026, Invitrogen), and was reverse transcribed using Fast All-in-One RT Kit (ES-RT001, ES Science, China). RT-qPCR was performed in triplicate with SYBR Green Master Mix (DBI-2043, DBI bioscience, German) and LightCycler 480 Thermocycler (Roche, Basel, Switzerland). Primer sequences were listed in Supplementary Data&#160;<xref rid="MOESM7" ref-type="media">5</xref>. The results were normalized to &#946;-actin expression levels.</p></sec><sec id="Sec14"><title>Flow cytometry</title><p id="Par26">Macrophages were stained with the following fluorochrome-labeled antibodies after Fc block (564765, BD Biosciences, Franklin Lakes, New Jersey, USA): CD14 (550787, M5E2, BD Biosciences), CD86 (374203, BU63, Biolegend), CD80 (305207, 2D10, Biolegend). For intracellular staining, HMDMs were fixed and permeabilized by Cytofix/Cytoperm and Perm/Wash Buffer (BD Biosciences) and were stained with anti-CD68 antibody (333807, Y1/82&#8201;A, Biolegend) for 50&#8201;min on ice. Cells were immediately analyzed with a BD FACSAria II Flow cytometry (BD Biosciences) and data were processed by FlowJo (Tree Star, Woodburn, Oregon, USA).</p></sec><sec id="Sec15"><title>Western blot</title><p id="Par27">Total protein was extracted using RIPA buffer (HX-1862-2, Huaxingbio, China) with protease and phosphatase inhibitor cocktail (78442, Thermo Scientific, Waltham, Massachusetts, USA), quantified by BCA Protein Assay Kit (23225, Thermo Scientific), boiled at 95&#8201;&#176;C for 10&#8201;min with SDS, subjected to 10% SDS&#8211;PAGE, and then transferred to PVDF membranes (Bio-Rad, Hercules, California, USA). The membranes were blocked and incubated with the primary antibodies and then secondary antibodies. Chemiluminescent blots were detected by Tanon-5200 (Bio-Tanon, China), quantified by Image J v.1.50&#8201;g and normalized to &#946;-actin expression as relative expression. Primary antibodies used included anti-IRF5 (ab33478, Abcam), anti-STAT1 (9172&#8201;T, Cell Signaling Technology, Danvers, Massachusetts, USA), anti-phos-STAT1 (7649&#8201;T, Cell Signaling Technology) and anti-&#946;-actin (ab8227, Abcam).</p></sec><sec id="Sec16"><title>Small RNA transfection</title><p id="Par28">miRNA mimic (30&#8201;nM, RiboPharm, China) (including miR-122-5p (miR10000421-1-5), miR-134-5p (miR10000447-1-5) and miR-6501-5p (miR1CM001)), miRNA inhibitor (30&#8201;nM, RiboPharm) (including miR-122-5p inhibitor (miR20000421-1-5), miR-134-5p (miR20000447-1-5) and miR-6501-5p (miR1CM001)) and siRNA (50&#8201;nM, GenePharma, China) were transfected into macrophages using RNAimax (13778150, Life Technologies Corporation) according to manufacturer&#8217;s instructions. siRNA sequences were listed in Supplementary Data&#160;<xref rid="MOESM7" ref-type="media">5</xref>.</p></sec><sec id="Sec17"><title>Dual-luciferase assay</title><p id="Par29">HEK293T cells (Procell) were transfected with 0.5ug wild-type or mutant IRF5 3&#8217;UTR (Supplementary Data&#160;<xref rid="MOESM7" ref-type="media">5</xref>) pmirGLO Dual-Luciferase miRNA Target Expression Vector (GenePharma, China) by lipofectamine 3000 (L3000015, Life Technologies Corporation), and 30&#8201;nM miR-122-5p by RNAimax. Cells were collected after 24&#8201;h to perform dual-luciferase reporter assay (E1910, Promega Corporation, USA). Data were normalized by firefly luciferase activity to Renella luciferase activity.</p></sec><sec id="Sec18"><title>miRNA sequencing and data analysis</title><p id="Par30">miRNA sequencing was conducted on Illumina HiSeq2500 platform (Illumina, San Diego, California, USA). Raw data of fastq format were processed through in-house perl scripts to obtain clean reads and the sequences kept were between 18nt and 32nt. Using Bowtie tools soft, the Clean Reads were mapped to genes from with Silva database, GtRNAdb database, Rfam database and Repbase database to filter ribosomal RNA (rRNA), transfer RNA (tRNA), small nuclear RNA (snRNA), small nucleolar RNA (snoRNA) and other ncRNA and repeats. The remaining reads were used to detect known miRNA and novel miRNA predicted by comparing with Genome and known miRNAs from miRBase. The count matrix was analyzed using DESeq2 (v1.30.0). Differentially expressed genes (DEGs) were identified with threshold of |log2 (Fold Change)|&gt;&#8201;2 and <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05.</p></sec><sec id="Sec19"><title>Bulk RNA sequencing and data analysis</title><p id="Par31">Bulk RNA sequencing was conducted on Illumina Novaseq 6000 (Illumina), and 150&#8201;bp paired-end reads were generated. The reads were QCed using FastQC and were mapped to the GRCh38 reference human genome using HISAT2 (v2.0.5), and feature Counts (v1.5.0) was applied to count the reads mapped to each gene. The count matrix was analyzed using DESeq2 (v1.30.0). DEGs were identified with a threshold of |log2 (Fold Change)|&gt;&#8201;0.8, adjusted <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01 and baseMean &#8805;100. Detailed procedures are accessible on Gene Expression Omnibus (GEO) database (accession no. <ext-link ext-link-type="pmc:entrez-geo" xlink:href="GSE252885">GSE252885</ext-link>).</p><p id="Par32">The pathways from Kyoto Encyclopedia of Genes and Genomes (KEGG) database were assessed by Gene set enrichment analysis (GSEA) using clusterProfiler (v3.0.4). Significantly enriched pathways were determined by the threshold of |normalized enrichment score&#8201;|&#8201;&#8805;1, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 and adjusted <italic toggle="yes">p</italic>&#8201;&lt;&#8201;=0.25.</p><p id="Par33">miRanda was used to predict the target of miR-122-5p among downregulated differentially expressed transcriptional factors (DETF) by the threshold of score threshold(-sc)&gt;&#8201;150 and energy(en)&lt;&#8201;&#8722;20. The downstream regulated DEGs of candidate DETFs were filtered by ChEA3 Database and Pearson correlation coefficient&gt;&#8201;0.9. Finally, pathways from KEGG database were assessed by hypergeometric testing in downstream regulated DEGs of certain candidate DETF. Significantly enriched pathways were determined with <italic toggle="yes">p&#8201;</italic>&lt;&#8201;0.05.</p></sec><sec id="Sec20"><title>Animal experiment</title><p id="Par34">Six- to eight-week-old C57BL/6&#8201;J mice were obtained from GemPharmatech (Strain NO. N000013) and were housed in a specific pathogen-free (SPF) facility, in a room with standard ambient temperature and humidity, and the animals had unrestricted access to food (Xietong Organism, 1010001) and water, with a 12-h light/dark cycle. Female and male mice were evenly and randomly assigned to groups to receive intraperitoneal injection with miR122-5p agomir (10&#8201;&#181;M, miR40000246-4-5, Ribobio, China) or PBS followed by 10&#8201;ng LPS after 24&#8201;h. 4&#8201;h later, mice were euthanized by carbon dioxide (CO2) asphyxiation inhalation, and cervical dislocation was performed as a secondary euthanasia procedure. And then peritoneal macrophages were harvested and were isolated with anti-F4/80 MicroBeads UltraPure (Miltenyi Biotec). TNF, IL-6, IRF5, CD80, and CD86 expression in peritoneal macrophages were detected by qRT-PCR, with &#946;-actin as the internal reference gene. All animal studies were approved by the Animal Ethics Committee of PUMCH (Approval No.: XHDW-2024-225).</p></sec><sec id="Sec21"><title>Statistical analysis</title><p id="Par35">Data were summarized as mean&#8201;&#177;&#8201;standard deviation (SD) or median and interquartile range. To compare two groups, independent-sample or paired t-test was used for normally distributed variables, and Wilcoxon rank-sum test was used for non-normally distributed variables. One-way ANOVA test or two-way ANOVA was used for multiple comparisons with adjusted p using two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli. A two-tailed <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 was considered statistically significant. Correlations were calculated using Pearson correlation analysis. A two-sided <italic toggle="yes">p</italic> value&#8201;&lt;&#8201;0.05 was considered statistically significant, with <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 indicating significant differences. All statistical analyses were performed using SPSS v.17.0 and R v4.0.2.</p></sec><sec id="Sec22"><title>Reporting summary</title><p id="Par36">Further information on research design is available in the&#160;<xref rid="MOESM8" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec23" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM3_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM4_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary Data 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM5_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary Data 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM6_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary Data 4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM7_ESM.xlsx" position="float" orientation="portrait"><caption><p>Supplementary Data 5</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM8_ESM.pdf" position="float" orientation="portrait"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM9_ESM.pdf" position="float" orientation="portrait"><caption><p>Transparent Peer Review file</p></caption></media></supplementary-material>
</p></sec><sec id="Sec24" sec-type="supplementary-material"><title>Source data</title><p>
<supplementary-material content-type="local-data" id="MOESM10" position="float" orientation="portrait"><media xlink:href="41467_2025_63348_MOESM10_ESM.xlsx" position="float" orientation="portrait"><caption><p>Source Data</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Xin Yu, Menghao Zhang, Na Kang, Chaoran Li.</p></fn><fn><p>These authors jointly supervised this work: &#160;Hua Chen, Wenjie Zheng.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-025-63348-8.</p></sec><ack><title>Acknowledgements</title><p>This work was supported by National Natural Science Foundation of China [grant number 81871299-W.Z., 82371822-W.Z., 82171800-W.Z.], Natural Science Foundation of Beijing [grant number 7232124-W.Z.], and National High Level Hospital Clinical Research Funding [grant number 2022-PUMCH-C-008-W.Z.] and CAMS Innovation Fund for Medical Sciences [grant number 2022-I2M-1-012-H.C., 2023-I2M-C&amp;T-B-049-W.Z.], Peking Union Medical College Hospital Talent Cultivation Program [grant number UBJ10289-H.C.], and Postdoctoral Fellowship Program of CPSF[grant number GZC 20240153-X.Y]. We thank the health professional staff from the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital and appreciate for the participation of all the patients and healthy volunteers in this study.&#160;Source data are provided with this paper.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>H.C. and W.Z. conceptualized and designed the project and supervised the project. X.Y. conducted the bioinformatics analysis with help from N.K. X.Y., M.Z. and C.L. performed the experiments and verified the underlying data reported in the manuscript with the help from Z.W., Y.A., and L.L. M.Z., Z.W., X.W., and Y.L. participated in the sample collection and clinical analysis, with the help of L.Z., L.W., M.S., and J.L. X.Y. and M.Z. drafted the manuscript. W.Z., H.C., Y.Z. and F.Z. critically reviewed the manuscript and provided valuable input. All authors read and approved the manuscript.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par37"><italic toggle="yes">Nature Communications</italic> thanks Giacomo Emmi who co-reviewed with Alessandra Bettiol; Akihiro Ishizu, Joaqu&#237;n Marco-Brualla and the other anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p></sec></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data are included in the Supplementary Information or available from the authors, as are unique reagents used in this article. The raw numbers for charts and graphs are available in the Source Data file whenever possible. The raw data and metadata of RNA-sequencing data have been deposited in the Gene Expression Omnibus (GEO) database (accession no. <ext-link ext-link-type="pmc:entrez-geo" xlink:href="GSE252885">GSE252885</ext-link>, the website hyperlink: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252885">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252885</ext-link>), and the miRNA sequencing data has been deposited in the National Genomics Data Center (NGDC) database (accession no. HRA007352, the website hyperlink: <ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa-human/browse/HRA007352">https://ngdc.cncb.ac.cn/gsa-human/browse/HRA007352</ext-link>).</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par38">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattioli</surname><given-names>I</given-names></name><name name-style="western"><surname>Bettiol</surname><given-names>A</given-names></name><name name-style="western"><surname>Saruhan-Direskeneli</surname><given-names>G</given-names></name><name name-style="western"><surname>Direskeneli</surname><given-names>H</given-names></name><name name-style="western"><surname>Emmi</surname><given-names>G</given-names></name></person-group><article-title>Pathogenesis of Beh&#231;et&#8217;s syndrome: genetic, environmental and immunological factors</article-title><source>Front Med (Lausanne)</source><year>2021</year><volume>8</volume><fpage>713052</fpage><pub-id pub-id-type="pmid">34692721</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2021.713052</pub-id><pub-id pub-id-type="pmcid">PMC8531401</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Mattioli, I., Bettiol, A., Saruhan-Direskeneli, G., Direskeneli, H. &amp; Emmi, G. Pathogenesis of Beh&#231;et&#8217;s syndrome: genetic, environmental and immunological factors. <italic toggle="yes">Front Med (Lausanne)</italic><bold>8</bold>, 713052 (2021).<pub-id pub-id-type="pmid">34692721</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2021.713052</pub-id><pub-id pub-id-type="pmcid">PMC8531401</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perazzio</surname><given-names>SF</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>LEC</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>AWS</given-names></name></person-group><article-title>Understanding Beh&#231;et&#8217;s disease in the context of innate immunity activation</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><fpage>586558</fpage><pub-id pub-id-type="pmid">33193413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.586558</pub-id><pub-id pub-id-type="pmcid">PMC7606308</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Perazzio, S. F., Andrade, L. E. C. &amp; de Souza, A. W. S. Understanding Beh&#231;et&#8217;s disease in the context of innate immunity activation. <italic toggle="yes">Front. Immunol.</italic><bold>11</bold>, 586558 (2020).<pub-id pub-id-type="pmid">33193413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.586558</pub-id><pub-id pub-id-type="pmcid">PMC7606308</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Tedeschi V. et al<italic toggle="yes">.</italic> The impact of the &#8216;mis-peptidome&#8217; on HLA class i-mediated diseases: contribution of ERAP1 and ERAP2 and effects on the immune response. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>21</bold>, 9608 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21249608</pub-id><pub-id pub-id-type="pmcid">PMC7765998</pub-id><pub-id pub-id-type="pmid">33348540</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayasaki</surname><given-names>N</given-names></name><etal/></person-group><article-title>Neutrophilic phlebitis is characteristic of intestinal Beh&#231;et&#8217;s disease and simple ulcer syndrome</article-title><source>Histopathology</source><year>2004</year><volume>45</volume><fpage>377</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">15469476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2559.2004.01954.x</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Hayasaki, N. et al. Neutrophilic phlebitis is characteristic of intestinal Beh&#231;et&#8217;s disease and simple ulcer syndrome. <italic toggle="yes">Histopathology</italic><bold>45</bold>, 377&#8211;383 (2004).<pub-id pub-id-type="pmid">15469476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2559.2004.01954.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><etal/></person-group><article-title>Neutrophil extracellular traps promote aberrant macrophages activation in Beh&#231;et&#8217;s disease</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><fpage>590622</fpage><pub-id pub-id-type="pmid">33633724</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.590622</pub-id><pub-id pub-id-type="pmcid">PMC7901995</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Li, L. et al. Neutrophil extracellular traps promote aberrant macrophages activation in Beh&#231;et&#8217;s disease. <italic toggle="yes">Front. Immunol.</italic><bold>11</bold>, 590622 (2020).<pub-id pub-id-type="pmid">33633724</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.590622</pub-id><pub-id pub-id-type="pmcid">PMC7901995</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Beh&#231;et&#8217;s disease</article-title><source>J. Dermatol Sci.</source><year>2018</year><volume>92</volume><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">30237006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jdermsci.2018.08.010</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Safi, R. et al. Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Beh&#231;et&#8217;s disease. <italic toggle="yes">J. Dermatol Sci.</italic><bold>92</bold>, 143&#8211;150 (2018).<pub-id pub-id-type="pmid">30237006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jdermsci.2018.08.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Macrophage polarization toward M1 phenotype through NF-&#954;B signaling in patients with Beh&#231;et&#8217;s disease</article-title><source>Arthritis Res. Ther.</source><year>2022</year><volume>24</volume><fpage>249</fpage><pub-id pub-id-type="pmid">36333776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13075-022-02938-z</pub-id><pub-id pub-id-type="pmcid">PMC9635113</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Wu, X. et al. Macrophage polarization toward M1 phenotype through NF-&#954;B signaling in patients with Beh&#231;et&#8217;s disease. <italic toggle="yes">Arthritis Res. Ther.</italic><bold>24</bold>, 249 (2022).<pub-id pub-id-type="pmid">36333776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13075-022-02938-z</pub-id><pub-id pub-id-type="pmcid">PMC9635113</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawrence</surname><given-names>SahinS</given-names></name><name name-style="western"><surname>Direskeneli</surname><given-names>R</given-names></name><name name-style="western"><surname>Hamuryudan</surname><given-names>H</given-names></name><name name-style="western"><surname>Yazici</surname><given-names>V</given-names></name><name name-style="western"><surname>Ako&#287;lu</surname><given-names>H</given-names></name></person-group><article-title>T. Monocyte activity in Beh&#231;et&#8217;s disease</article-title><source>Br. J. Rheumatol.</source><year>1996</year><volume>35</volume><fpage>424</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">8646431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rheumatology/35.5.424</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Lawrence, S. ahinS., Direskeneli, R., Hamuryudan, H., Yazici, V. &amp; Ako&#287;lu, H. T. Monocyte activity in Beh&#231;et&#8217;s disease. <italic toggle="yes">Br. J. Rheumatol.</italic><bold>35</bold>, 424&#8211;429 (1996).<pub-id pub-id-type="pmid">8646431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rheumatology/35.5.424</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Transcriptional analysis of neutrophils from patients with Beh&#231;et&#8217;s disease reveals activation and chemotaxis of neutrophils</article-title><source>Clin. Immunol.</source><year>2022</year><volume>245</volume><fpage>109161</fpage><pub-id pub-id-type="pmid">36243348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clim.2022.109161</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Yu, X. et al. Transcriptional analysis of neutrophils from patients with Beh&#231;et&#8217;s disease reveals activation and chemotaxis of neutrophils. <italic toggle="yes">Clin. Immunol.</italic><bold>245</bold>, 109161 (2022).<pub-id pub-id-type="pmid">36243348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clim.2022.109161</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Verrou K. M., et al<italic toggle="yes">.</italic><italic toggle="yes">Distinct Transcriptional Profile Of Blood Mononuclear Cells In Behcet&#8217;s Disease: Insights Into The Central Role Of Neutrophil Chemotaxis</italic>. Rheumatology (Oxford). (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rheumatology/keab052</pub-id><pub-id pub-id-type="pmid">33493315</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name><etal/></person-group><article-title>Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Beh&#231;et&#8217;s disease</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2022</year><volume>119</volume><fpage>e2204289119</fpage><pub-id pub-id-type="pmid">35727985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2204289119</pub-id><pub-id pub-id-type="pmcid">PMC9245671</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Zheng, W. et al. Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Beh&#231;et&#8217;s disease. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>119</bold>, e2204289119 (2022).<pub-id pub-id-type="pmid">35727985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2204289119</pub-id><pub-id pub-id-type="pmcid">PMC9245671</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kowal</surname><given-names>J</given-names></name><name name-style="western"><surname>Tkach</surname><given-names>M</given-names></name><name name-style="western"><surname>Th&#233;ry</surname><given-names>C</given-names></name></person-group><article-title>Biogenesis and secretion of exosomes</article-title><source>Curr. Opin. Cell Biol.</source><year>2014</year><volume>29</volume><fpage>116</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">24959705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ceb.2014.05.004</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Kowal, J., Tkach, M. &amp; Th&#233;ry, C. Biogenesis and secretion of exosomes. <italic toggle="yes">Curr. Opin. Cell Biol.</italic><bold>29</bold>, 116&#8211;125 (2014).<pub-id pub-id-type="pmid">24959705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ceb.2014.05.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Konaka</surname><given-names>H</given-names></name><etal/></person-group><article-title>Secretion of mitochondrial DNA via exosomes promotes inflammation in Beh&#231;et&#8217;s syndrome</article-title><source>EMBO J.</source><year>2023</year><volume>42</volume><fpage>e112573</fpage><pub-id pub-id-type="pmid">37661814</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.2022112573</pub-id><pub-id pub-id-type="pmcid">PMC10577637</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Konaka, H. et al. Secretion of mitochondrial DNA via exosomes promotes inflammation in Beh&#231;et&#8217;s syndrome. <italic toggle="yes">EMBO J.</italic><bold>42</bold>, e112573 (2023).<pub-id pub-id-type="pmid">37661814</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embj.2022112573</pub-id><pub-id pub-id-type="pmcid">PMC10577637</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>J</given-names></name><etal/></person-group><article-title>Plasma-derived exosomal protein SHP2 deficiency induces neutrophil hyperactivation in Behcet&#8217;s uveitis</article-title><source>Exp. eye Res.</source><year>2024</year><volume>239</volume><fpage>109785</fpage><pub-id pub-id-type="pmid">38211682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.exer.2024.109785</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Cai, J. et al. Plasma-derived exosomal protein SHP2 deficiency induces neutrophil hyperactivation in Behcet&#8217;s uveitis. <italic toggle="yes">Exp. eye Res.</italic><bold>239</bold>, 109785 (2024).<pub-id pub-id-type="pmid">38211682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.exer.2024.109785</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genschmer</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>113</fpage><lpage>26.e15</lpage><pub-id pub-id-type="pmid">30633902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2018.12.002</pub-id><pub-id pub-id-type="pmcid">PMC6368091</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Genschmer, K. R. et al. Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung. <italic toggle="yes">Cell</italic><bold>176</bold>, 113&#8211;26.e15 (2019).<pub-id pub-id-type="pmid">30633902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2018.12.002</pub-id><pub-id pub-id-type="pmcid">PMC6368091</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes</article-title><source>FASEB J.</source><year>2019</year><volume>33</volume><fpage>6813</fpage><lpage>6828</lpage><pub-id pub-id-type="pmid">30811955</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.201802090RR</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Shao, S. et al. Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes. <italic toggle="yes">FASEB J.</italic><bold>33</bold>, 6813&#8211;6828 (2019).<pub-id pub-id-type="pmid">30811955</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.201802090RR</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gasser</surname><given-names>O</given-names></name><name name-style="western"><surname>Schifferli</surname><given-names>JA</given-names></name></person-group><article-title>Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis</article-title><source>Blood</source><year>2004</year><volume>104</volume><fpage>2543</fpage><pub-id pub-id-type="pmid">15213101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2004-01-0361</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Gasser, O. &amp; Schifferli, J. A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. <italic toggle="yes">Blood</italic><bold>104</bold>, 2543 (2004).<pub-id pub-id-type="pmid">15213101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2004-01-0361</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhan</surname><given-names>D</given-names></name><etal/></person-group><article-title>Internalization of neutrophil-derived microvesicles modulates tnf&#945;-stimulated proinflammatory cytokine production in human fibroblast-like synoviocytes</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><fpage>7409</fpage><pub-id pub-id-type="pmid">34299030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22147409</pub-id><pub-id pub-id-type="pmcid">PMC8304992</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Zhan, D. et al. Internalization of neutrophil-derived microvesicles modulates tnf&#945;-stimulated proinflammatory cytokine production in human fibroblast-like synoviocytes. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>22</bold>, 7409 (2021).<pub-id pub-id-type="pmid">34299030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22147409</pub-id><pub-id pub-id-type="pmcid">PMC8304992</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cumpelik</surname><given-names>A</given-names></name><name name-style="western"><surname>Ankli</surname><given-names>B</given-names></name><name name-style="western"><surname>Zecher</surname><given-names>D</given-names></name><name name-style="western"><surname>Schifferli</surname><given-names>JA</given-names></name></person-group><article-title>Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome</article-title><source>Ann. Rheum. Dis.</source><year>2016</year><volume>75</volume><fpage>1236</fpage><lpage>1245</lpage><pub-id pub-id-type="pmid">26245757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2015-207338</pub-id><pub-id pub-id-type="pmcid">PMC4893114</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Cumpelik, A., Ankli, B., Zecher, D. &amp; Schifferli, J. A. Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome. <italic toggle="yes">Ann. Rheum. Dis.</italic><bold>75</bold>, 1236&#8211;1245 (2016).<pub-id pub-id-type="pmid">26245757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2015-207338</pub-id><pub-id pub-id-type="pmcid">PMC4893114</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pliyev</surname><given-names>BK</given-names></name><name name-style="western"><surname>Kalintseva</surname><given-names>MV</given-names></name><name name-style="western"><surname>Abdulaeva</surname><given-names>SV</given-names></name><name name-style="western"><surname>Yarygin</surname><given-names>KN</given-names></name><name name-style="western"><surname>Savchenko</surname><given-names>VG</given-names></name></person-group><article-title>Neutrophil microparticles modulate cytokine production by natural killer cells</article-title><source>Cytokine</source><year>2014</year><volume>65</volume><fpage>126</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">24355430</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cyto.2013.11.010</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Pliyev, B. K., Kalintseva, M. V., Abdulaeva, S. V., Yarygin, K. N. &amp; Savchenko, V. G. Neutrophil microparticles modulate cytokine production by natural killer cells. <italic toggle="yes">Cytokine</italic><bold>65</bold>, 126&#8211;129 (2014).<pub-id pub-id-type="pmid">24355430</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cyto.2013.11.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>K</given-names></name><name name-style="western"><surname>Sumagin</surname><given-names>R</given-names></name><name name-style="western"><surname>Hyun</surname><given-names>Y-M</given-names></name></person-group><article-title>Extravasating neutrophil-derived microparticles preserve vascular barrier function in inflamed tissue</article-title><source>Immune Netw.</source><year>2013</year><volume>13</volume><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">23885224</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4110/in.2013.13.3.102</pub-id><pub-id pub-id-type="pmcid">PMC3718920</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Lim, K., Sumagin, R. &amp; Hyun, Y.-M. Extravasating neutrophil-derived microparticles preserve vascular barrier function in inflamed tissue. <italic toggle="yes">Immune Netw.</italic><bold>13</bold>, 102&#8211;106 (2013).<pub-id pub-id-type="pmid">23885224</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4110/in.2013.13.3.102</pub-id><pub-id pub-id-type="pmcid">PMC3718920</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Headland</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis</article-title><source>Sci. Transl. Med.</source><year>2015</year><volume>7</volume><fpage>315</fpage><lpage>ra190</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aac5608</pub-id><pub-id pub-id-type="pmcid">PMC6034622</pub-id><pub-id pub-id-type="pmid">26606969</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Headland, S. E. et al. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. <italic toggle="yes">Sci. Transl. Med.</italic><bold>7</bold>, 315&#8211;ra190 (2015).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aac5608</pub-id><pub-id pub-id-type="pmcid">PMC6034622</pub-id><pub-id pub-id-type="pmid">26606969</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Qiu P., Zhou J., Zhang J., Dong Y., Liu Y. Exosome: the regulator of the immune system in sepsis. <italic toggle="yes">Front. Pharmacol</italic>. <bold>12</bold>, 671164 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2021.671164</pub-id><pub-id pub-id-type="pmcid">PMC8113812</pub-id><pub-id pub-id-type="pmid">33995102</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalli</surname><given-names>J</given-names></name><etal/></person-group><article-title>Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles</article-title><source>Blood</source><year>2008</year><volume>112</volume><fpage>2512</fpage><lpage>2519</lpage><pub-id pub-id-type="pmid">18594025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2008-02-140533</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Dalli, J. et al. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. <italic toggle="yes">Blood</italic><bold>112</bold>, 2512&#8211;2519 (2008).<pub-id pub-id-type="pmid">18594025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2008-02-140533</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eken</surname><given-names>C</given-names></name><etal/></person-group><article-title>Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells</article-title><source>J. Immunol.</source><year>2008</year><volume>180</volume><fpage>817</fpage><lpage>824</lpage><pub-id pub-id-type="pmid">18178820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.180.2.817</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Eken, C. et al. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. <italic toggle="yes">J. Immunol.</italic><bold>180</bold>, 817&#8211;824 (2008).<pub-id pub-id-type="pmid">18178820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.180.2.817</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mege</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh&#231;et&#8217;s disease. A comparative study with familial Mediterranean fever and healthy subjects</article-title><source>J. Rheumatol.</source><year>1993</year><volume>20</volume><fpage>1544</fpage><lpage>1549</lpage><pub-id pub-id-type="pmid">8164212</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Mege, J. L. et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh&#231;et&#8217;s disease. A comparative study with familial Mediterranean fever and healthy subjects. <italic toggle="yes">J. Rheumatol.</italic><bold>20</bold>, 1544&#8211;1549 (1993).<pub-id pub-id-type="pmid">8164212</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirahara</surname><given-names>L</given-names></name><etal/></person-group><article-title>The roles of monocytes and macrophages in Beh&#231;et&#8217;s disease with focus on M1 and M2 polarization</article-title><source>Front. Immunol.</source><year>2022</year><volume>13</volume><fpage>852297</fpage><pub-id pub-id-type="pmid">35359926</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2022.852297</pub-id><pub-id pub-id-type="pmcid">PMC8963421</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Hirahara, L. et al. The roles of monocytes and macrophages in Beh&#231;et&#8217;s disease with focus on M1 and M2 polarization. <italic toggle="yes">Front. Immunol.</italic><bold>13</bold>, 852297 (2022).<pub-id pub-id-type="pmid">35359926</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2022.852297</pub-id><pub-id pub-id-type="pmcid">PMC8963421</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibrahim</surname><given-names>W</given-names></name><name name-style="western"><surname>Sakr</surname><given-names>BR</given-names></name><name name-style="western"><surname>Obaya</surname><given-names>E</given-names></name><name name-style="western"><surname>Ghonem</surname><given-names>H</given-names></name></person-group><article-title>MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet&#8217;s disease patients</article-title><source>Clin. Rheumatol.</source><year>2019</year><volume>38</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">29987428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10067-018-4191-2</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Ibrahim, W., Sakr, B. R., Obaya, E. &amp; Ghonem, H. MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet&#8217;s disease patients. <italic toggle="yes">Clin. Rheumatol.</italic><bold>38</bold>, 397&#8211;402 (2019).<pub-id pub-id-type="pmid">29987428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10067-018-4191-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdelaleem</surname><given-names>OO</given-names></name><etal/></person-group><article-title>Association of miR-146a rs57095329 with Beh&#231;et&#8217;s disease and its complications</article-title><source>Br. J. Biomed. Sci.</source><year>2021</year><volume>78</volume><fpage>63</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">32569501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09674845.2020.1786284</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Abdelaleem, O. O. et al. Association of miR-146a rs57095329 with Beh&#231;et&#8217;s disease and its complications. <italic toggle="yes">Br. J. Biomed. Sci.</italic><bold>78</bold>, 63&#8211;66 (2021).<pub-id pub-id-type="pmid">32569501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09674845.2020.1786284</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Na</surname><given-names>SY</given-names></name><name name-style="western"><surname>Park</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>ES</given-names></name></person-group><article-title>MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Beh&#231;et&#8217;s disease</article-title><source>Clin. Exp. Rheumatol.</source><year>2016</year><volume>34</volume><fpage>S56</fpage><lpage>s63</lpage><pub-id pub-id-type="pmid">27156371</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Na, S. Y., Park, M. J., Park, S. &amp; Lee, E. S. MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Beh&#231;et&#8217;s disease. <italic toggle="yes">Clin. Exp. Rheumatol.</italic><bold>34</bold>, S56&#8211;s63 (2016).<pub-id pub-id-type="pmid">27156371</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Decreased microRNA-155 expression in ocular Behcet&#8217;s disease but not in Vogt Koyanagi Harada syndrome</article-title><source>Investigative Ophthalmol. Vis. Sci.</source><year>2012</year><volume>53</volume><fpage>5665</fpage><lpage>5674</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.12-9832</pub-id><pub-id pub-id-type="pmid">22815348</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Zhou, Q. et al. Decreased microRNA-155 expression in ocular Behcet&#8217;s disease but not in Vogt Koyanagi Harada syndrome. <italic toggle="yes">Investigative Ophthalmol. Vis. Sci.</italic><bold>53</bold>, 5665&#8211;5674 (2012).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.12-9832</pub-id><pub-id pub-id-type="pmid">22815348</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chasset</surname><given-names>F</given-names></name><name name-style="western"><surname>Dayer</surname><given-names>J-M</given-names></name><name name-style="western"><surname>Chizzolini</surname><given-names>C</given-names></name></person-group><article-title>Type I interferons in systemic autoimmune diseases: distinguishing between afferent and efferent functions for precision medicine and individualized treatment</article-title><source>Front. Pharmacol.</source><year>2021</year><volume>12</volume><fpage>633821</fpage><pub-id pub-id-type="pmid">33986670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2021.633821</pub-id><pub-id pub-id-type="pmcid">PMC8112244</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Chasset, F., Dayer, J.-M. &amp; Chizzolini, C. Type I interferons in systemic autoimmune diseases: distinguishing between afferent and efferent functions for precision medicine and individualized treatment. <italic toggle="yes">Front. Pharmacol.</italic><bold>12</bold>, 633821 (2021).<pub-id pub-id-type="pmid">33986670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2021.633821</pub-id><pub-id pub-id-type="pmcid">PMC8112244</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neves</surname><given-names>FS</given-names></name><name name-style="western"><surname>Spiller</surname><given-names>F</given-names></name></person-group><article-title>Possible mechanisms of neutrophil activation in Beh&#231;et&#8217;s disease</article-title><source>Int. Immunopharmacol.</source><year>2013</year><volume>17</volume><fpage>1206</fpage><lpage>1210</lpage><pub-id pub-id-type="pmid">23973446</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2013.07.017</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Neves, F. S. &amp; Spiller, F. Possible mechanisms of neutrophil activation in Beh&#231;et&#8217;s disease. <italic toggle="yes">Int. Immunopharmacol.</italic><bold>17</bold>, 1206&#8211;1210 (2013).<pub-id pub-id-type="pmid">23973446</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2013.07.017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Joncour</surname><given-names>A</given-names></name><etal/></person-group><article-title>Critical role of neutrophil extracellular traps (NETs) in patients with Behcet&#8217;s disease</article-title><source>Ann. Rheum. Dis.</source><year>2019</year><volume>78</volume><fpage>1274</fpage><lpage>1282</lpage><pub-id pub-id-type="pmid">31147357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2018-214335</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Le Joncour, A. et al. Critical role of neutrophil extracellular traps (NETs) in patients with Behcet&#8217;s disease. <italic toggle="yes">Ann. Rheum. Dis.</italic><bold>78</bold>, 1274&#8211;1282 (2019).<pub-id pub-id-type="pmid">31147357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2018-214335</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schett</surname><given-names>G</given-names></name><name name-style="western"><surname>Neurath</surname><given-names>MF</given-names></name></person-group><article-title>Resolution of chronic inflammatory disease: universal and tissue-specific concepts</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>3261</fpage><pub-id pub-id-type="pmid">30111884</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-05800-6</pub-id><pub-id pub-id-type="pmcid">PMC6093916</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Schett, G. &amp; Neurath, M. F. Resolution of chronic inflammatory disease: universal and tissue-specific concepts. <italic toggle="yes">Nat. Commun.</italic><bold>9</bold>, 3261 (2018).<pub-id pub-id-type="pmid">30111884</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-05800-6</pub-id><pub-id pub-id-type="pmcid">PMC6093916</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herrero-Cervera</surname><given-names>A</given-names></name><name name-style="western"><surname>Soehnlein</surname><given-names>O</given-names></name><name name-style="western"><surname>Kenne</surname><given-names>E</given-names></name></person-group><article-title>Neutrophils in chronic inflammatory diseases</article-title><source>Cell. Mol. Immunol.</source><year>2022</year><volume>19</volume><fpage>177</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">35039631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-021-00832-3</pub-id><pub-id pub-id-type="pmcid">PMC8803838</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Herrero-Cervera, A., Soehnlein, O. &amp; Kenne, E. Neutrophils in chronic inflammatory diseases. <italic toggle="yes">Cell. Mol. Immunol.</italic><bold>19</bold>, 177&#8211;191 (2022).<pub-id pub-id-type="pmid">35039631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-021-00832-3</pub-id><pub-id pub-id-type="pmcid">PMC8803838</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pillay</surname><given-names>J</given-names></name><etal/></person-group><article-title>A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1</article-title><source>J. Clin. Invest</source><year>2012</year><volume>122</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">22156198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI57990</pub-id><pub-id pub-id-type="pmcid">PMC3248287</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Pillay, J. et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. <italic toggle="yes">J. Clin. Invest</italic><bold>122</bold>, 327&#8211;336 (2012).<pub-id pub-id-type="pmid">22156198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI57990</pub-id><pub-id pub-id-type="pmcid">PMC3248287</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zehntner</surname><given-names>SP</given-names></name><etal/></person-group><article-title>Neutrophils that infiltrate the central nervous system regulate T cell responses</article-title><source>J. Immunol.</source><year>2005</year><volume>174</volume><fpage>5124</fpage><lpage>5131</lpage><pub-id pub-id-type="pmid">15814744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.174.8.5124</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Zehntner, S. P. et al. Neutrophils that infiltrate the central nervous system regulate T cell responses. <italic toggle="yes">J. Immunol.</italic><bold>174</bold>, 5124&#8211;5131 (2005).<pub-id pub-id-type="pmid">15814744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.174.8.5124</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munder</surname><given-names>M</given-names></name><etal/></person-group><article-title>Suppression of T-cell functions by human granulocyte arginase</article-title><source>Blood</source><year>2006</year><volume>108</volume><fpage>1627</fpage><lpage>1634</lpage><pub-id pub-id-type="pmid">16709924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2006-11-010389</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Munder, M. et al. Suppression of T-cell functions by human granulocyte arginase. <italic toggle="yes">Blood</italic><bold>108</bold>, 1627&#8211;1634 (2006).<pub-id pub-id-type="pmid">16709924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2006-11-010389</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rhys</surname><given-names>HI</given-names></name><etal/></person-group><article-title>Neutrophil microvesicles from healthy control and rheumatoid arthritis patients prevent the inflammatory activation of macrophages</article-title><source>EBioMedicine</source><year>2018</year><volume>29</volume><fpage>60</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">29449195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ebiom.2018.02.003</pub-id><pub-id pub-id-type="pmcid">PMC5925578</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Rhys, H. I. et al. Neutrophil microvesicles from healthy control and rheumatoid arthritis patients prevent the inflammatory activation of macrophages. <italic toggle="yes">EBioMedicine</italic><bold>29</bold>, 60&#8211;69 (2018).<pub-id pub-id-type="pmid">29449195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ebiom.2018.02.003</pub-id><pub-id pub-id-type="pmcid">PMC5925578</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Zhang J, et al. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy. <italic toggle="yes">Sci. Adv</italic>. <bold>8</bold>, eabj8207 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.abj8207</pub-id><pub-id pub-id-type="pmcid">PMC8754405</pub-id><pub-id pub-id-type="pmid">35020437</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name></person-group><article-title>The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation</article-title><source>Int. J. Nanomed.</source><year>2021</year><volume>16</volume><fpage>7663</fpage><lpage>7681</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S328705</pub-id><pub-id pub-id-type="pmcid">PMC8605828</pub-id><pub-id pub-id-type="pmid">34815670</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Wang, H., Zang, J., Zhao, Z., Zhang, Q. &amp; Chen, S. The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation. <italic toggle="yes">Int. J. Nanomed.</italic><bold>16</bold>, 7663&#8211;7681 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S328705</pub-id><pub-id pub-id-type="pmcid">PMC8605828</pub-id><pub-id pub-id-type="pmid">34815670</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn&#8217;s disease</article-title><source>Biochem Biophys. Res Commun.</source><year>2013</year><volume>438</volume><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">23872065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2013.07.040</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Chen, Y. et al. miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn&#8217;s disease. <italic toggle="yes">Biochem Biophys. Res Commun.</italic><bold>438</bold>, 133&#8211;139 (2013).<pub-id pub-id-type="pmid">23872065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2013.07.040</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>J</given-names></name><etal/></person-group><article-title>DNA Methylation of miR-122 aggravates oxidative stress in colitis targeting SELENBP1 partially by p65NF-&#954;B signaling</article-title><source>Oxid. Med. Cell. Longev.</source><year>2019</year><volume>2019</volume><fpage>5294105</fpage><pub-id pub-id-type="pmid">31019652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/5294105</pub-id><pub-id pub-id-type="pmcid">PMC6451819</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Bai, J. et al. DNA Methylation of miR-122 aggravates oxidative stress in colitis targeting SELENBP1 partially by p65NF-&#954;B signaling. <italic toggle="yes">Oxid. Med. Cell. Longev.</italic><bold>2019</bold>, 5294105 (2019).<pub-id pub-id-type="pmid">31019652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/5294105</pub-id><pub-id pub-id-type="pmcid">PMC6451819</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Z</given-names></name><etal/></person-group><article-title>MiR-122-5p mitigates inflammation, reactive oxygen species and SH-SY5Y apoptosis by targeting CPEB1 after spinal cord injury via the PI3K/AKT signaling pathway</article-title><source>Neurochem Res</source><year>2021</year><volume>46</volume><fpage>992</fpage><lpage>1005</lpage><pub-id pub-id-type="pmid">33528808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11064-021-03232-1</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Wei, Z. et al. MiR-122-5p mitigates inflammation, reactive oxygen species and SH-SY5Y apoptosis by targeting CPEB1 after spinal cord injury via the PI3K/AKT signaling pathway. <italic toggle="yes">Neurochem Res.</italic><bold>46</bold>, 992&#8211;1005 (2021).<pub-id pub-id-type="pmid">33528808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11064-021-03232-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>M</given-names></name><etal/></person-group><article-title>MicroRNA-122 inhibits the production of inflammatory cytokines by targeting the PKR activator PACT in human hepatic stellate cells</article-title><source>PLOS ONE</source><year>2015</year><volume>10</volume><fpage>e0144295</fpage><pub-id pub-id-type="pmid">26636761</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0144295</pub-id><pub-id pub-id-type="pmcid">PMC4670168</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Nakamura, M. et al. MicroRNA-122 inhibits the production of inflammatory cytokines by targeting the PKR activator PACT in human hepatic stellate cells. <italic toggle="yes">PLOS ONE</italic><bold>10</bold>, e0144295 (2015).<pub-id pub-id-type="pmid">26636761</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0144295</pub-id><pub-id pub-id-type="pmcid">PMC4670168</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name><name name-style="western"><surname>Chang</surname><given-names>R</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T</given-names></name></person-group><article-title>The long noncoding RNA MIR122HG is a precursor for miR-122-5p and negatively regulates the TAK1-induced innate immune response in teleost fish</article-title><source>J. Biol. Chem.</source><year>2022</year><volume>298</volume><fpage>101773</fpage><pub-id pub-id-type="pmid">35218771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbc.2022.101773</pub-id><pub-id pub-id-type="pmcid">PMC8935508</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Zheng, W., Chang, R., Luo, Q., Liu, G. &amp; Xu, T. The long noncoding RNA MIR122HG is a precursor for miR-122-5p and negatively regulates the TAK1-induced innate immune response in teleost fish. <italic toggle="yes">J. Biol. Chem.</italic><bold>298</bold>, 101773 (2022).<pub-id pub-id-type="pmid">35218771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbc.2022.101773</pub-id><pub-id pub-id-type="pmcid">PMC8935508</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rivkin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inflammation-induced expression and secretion of MicroRNA 122 leads to reduced blood levels of kidney-derived erythropoietin and anemia</article-title><source>Gastroenterology</source><year>2016</year><volume>151</volume><fpage>999</fpage><lpage>1010.e3</lpage><pub-id pub-id-type="pmid">27477940</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2016.07.031</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Rivkin, M. et al. Inflammation-induced expression and secretion of MicroRNA 122 leads to reduced blood levels of kidney-derived erythropoietin and anemia. <italic toggle="yes">Gastroenterology</italic><bold>151</bold>, 999&#8211;1010.e3 (2016).<pub-id pub-id-type="pmid">27477940</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2016.07.031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>A</given-names></name><etal/></person-group><article-title>MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2013</year><volume>45</volume><fpage>858</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">23348614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biocel.2013.01.008</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Li, A. et al. MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1. <italic toggle="yes">Int. J. Biochem. Cell Biol.</italic><bold>45</bold>, 858&#8211;865 (2013).<pub-id pub-id-type="pmid">23348614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biocel.2013.01.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshikawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Silencing of microRNA-122 enhances interferon-&#945; signaling in the liver through regulating SOCS3 promoter methylation</article-title><source>Sci. Rep.</source><year>2012</year><volume>2</volume><fpage>637</fpage><pub-id pub-id-type="pmid">22957141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep00637</pub-id><pub-id pub-id-type="pmcid">PMC3434395</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Yoshikawa, T. et al. Silencing of microRNA-122 enhances interferon-&#945; signaling in the liver through regulating SOCS3 promoter methylation. <italic toggle="yes">Sci. Rep.</italic><bold>2</bold>, 637 (2012).<pub-id pub-id-type="pmid">22957141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep00637</pub-id><pub-id pub-id-type="pmcid">PMC3434395</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colonna</surname><given-names>M</given-names></name></person-group><article-title>TLR pathways and IFN-regulatory factors: to each its own</article-title><source>Eur. J. Immunol.</source><year>2007</year><volume>37</volume><fpage>306</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">17273997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.200637009</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Colonna, M. TLR pathways and IFN-regulatory factors: to each its own. <italic toggle="yes">Eur. J. Immunol.</italic><bold>37</bold>, 306&#8211;309 (2007).<pub-id pub-id-type="pmid">17273997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.200637009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pattison</surname><given-names>MJ</given-names></name><name name-style="western"><surname>MacKenzie</surname><given-names>KF</given-names></name><name name-style="western"><surname>Elcombe</surname><given-names>SE</given-names></name><name name-style="western"><surname>Arthur</surname><given-names>JSC</given-names></name></person-group><article-title>IFN&#946; autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages</article-title><source>FEBS Lett.</source><year>2013</year><volume>587</volume><fpage>1496</fpage><lpage>1503</lpage><pub-id pub-id-type="pmid">23542035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.febslet.2013.03.025</pub-id><pub-id pub-id-type="pmcid">PMC3655261</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Pattison, M. J., MacKenzie, K. F., Elcombe, S. E. &amp; Arthur, J. S. C. IFN&#946; autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages. <italic toggle="yes">FEBS Lett.</italic><bold>587</bold>, 1496&#8211;1503 (2013).<pub-id pub-id-type="pmid">23542035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.febslet.2013.03.025</pub-id><pub-id pub-id-type="pmcid">PMC3655261</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gautier</surname><given-names>G</given-names></name><etal/></person-group><article-title>A type I interferon autocrine&#8211;paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells</article-title><source>J. Exp. Med.</source><year>2005</year><volume>201</volume><fpage>1435</fpage><lpage>1446</lpage><pub-id pub-id-type="pmid">15851485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20041964</pub-id><pub-id pub-id-type="pmcid">PMC2213193</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Gautier, G. et al. A type I interferon autocrine&#8211;paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. <italic toggle="yes">J. Exp. Med.</italic><bold>201</bold>, 1435&#8211;1446 (2005).<pub-id pub-id-type="pmid">15851485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20041964</pub-id><pub-id pub-id-type="pmcid">PMC2213193</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">Zhang R, et al. Caloric restriction induces MicroRNAs to improve mitochondrial proteostasis. <italic toggle="yes">iScience</italic>. <bold>17</bold>, 166 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.isci.2019.06.028</pub-id><pub-id pub-id-type="pmcid">PMC6614116</pub-id><pub-id pub-id-type="pmid">31279933</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Liang Y., et al. lncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM2. <italic toggle="yes">Oncogenesis</italic>. <bold>9</bold>, 54 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41389-020-0242-z</pub-id><pub-id pub-id-type="pmcid">PMC7256049</pub-id><pub-id pub-id-type="pmid">32467565</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="other">Kh C. et al. Molecular targets and signaling pathways of microRNA-122 in hepatocellular carcinoma. <italic toggle="yes">Pharmaceutics</italic>. <bold>14</bold>, 1380 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pharmaceutics14071380</pub-id><pub-id pub-id-type="pmcid">PMC9316959</pub-id><pub-id pub-id-type="pmid">35890276</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Liu Y, et al. Metabolic reprogramming in macrophage responses. <italic toggle="yes">Biomark. Res.</italic><bold>9</bold>, 1 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40364-020-00251-y</pub-id><pub-id pub-id-type="pmcid">PMC7786975</pub-id><pub-id pub-id-type="pmid">33407885</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">Batista-Gonzalez A, Vidal R, Criollo A, Carre&#241;o LJ. New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages. <italic toggle="yes">Front. immunol</italic>. <bold>10</bold>, 2993(2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2019.02993</pub-id><pub-id pub-id-type="pmcid">PMC6966486</pub-id><pub-id pub-id-type="pmid">31998297</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Exosomes containing miR-122-5p secreted by LPS-induced neutrophils regulate the apoptosis and permeability of brain microvascular endothelial cells by targeting OCLN</article-title><source>Am. J. Transl. Res.</source><year>2021</year><volume>13</volume><fpage>4167</fpage><lpage>4181</lpage><pub-id pub-id-type="pmid">34150006</pub-id><pub-id pub-id-type="pmcid">PMC8205764</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Li, Q. et al. Exosomes containing miR-122-5p secreted by LPS-induced neutrophils regulate the apoptosis and permeability of brain microvascular endothelial cells by targeting OCLN. <italic toggle="yes">Am. J. Transl. Res.</italic><bold>13</bold>, 4167&#8211;4181 (2021).<pub-id pub-id-type="pmid">34150006</pub-id><pub-id pub-id-type="pmcid">PMC8205764</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><collab>International Team for the Revision of the International Criteria for Beh&#231;et&#8217;s D.</collab></person-group><article-title>The International Criteria for Beh&#231;et&#8217;s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria</article-title><source>J. Eur. Acad. Dermatol Venereol.</source><year>2014</year><volume>28</volume><fpage>338</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">23441863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jdv.12107</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">International Team for the Revision of the International Criteria for Beh&#231;et&#8217;s D. The International Criteria for Beh&#231;et&#8217;s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. <italic toggle="yes">J. Eur. Acad. Dermatol Venereol.</italic><bold>28</bold>, 338&#8211;347 (2014).<pub-id pub-id-type="pmid">23441863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jdv.12107</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuijpers</surname><given-names>TW</given-names></name><etal/></person-group><article-title>Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation</article-title><source>Blood</source><year>1991</year><volume>78</volume><fpage>1105</fpage><lpage>1111</lpage><pub-id pub-id-type="pmid">1907873</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Kuijpers, T. W. et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. <italic toggle="yes">Blood</italic><bold>78</bold>, 1105&#8211;1111 (1991).<pub-id pub-id-type="pmid">1907873</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>